Komiyama Chinatsu, Kuwabara Masanari, Harima Ayako, Kanie Takayoshi, Yamaguchi Tetsuo, Kodama Takahide
Department of Cardiology, Toranomon Hospital.
Division of Public Health and Division of Cardiovascular Medicine, Jichi Medical University, Shimotsuke.
J Atheroscler Thromb. 2025 Apr 1;32(4):395-404. doi: 10.5551/jat.RV22032. Epub 2025 Jan 31.
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide, including in Japan, where the aging population intensifies its impact. This review evaluated the potential impact of digital healthcare on the prevention and management of ASCVD, covering both primary and secondary prevention strategies. Digital health tools, such as risk assessment applications remote monitoring, lifestyle modification support, and remote rehabilitation, have shown promise in improving patient engagement, adherence, and outcomes. However, while digital health interventions demonstrate significant benefits, challenges persist, including interoperability issues, privacy concerns, low digital literacy among older adults, and limited health insurance coverage for digital interventions. Through an analysis of recent advancements and case studies, this review demonstrates the need for user-centered design, enhanced regulatory frameworks, and expanded insurance support to facilitate the effective integration of digital health in ASCVD care. Furthermore, emerging technologies such as personalized healthcare modules offer promising directions for tailored and impactful care. Addressing these barriers is critical to unleashing the full potential of digital healthcare to reduce the burden of ASCVD and enhance patient outcomes.
动脉粥样硬化性心血管疾病(ASCVD)仍然是全球发病和死亡的主要原因,在日本亦是如此,该国人口老龄化加剧了其影响。本综述评估了数字医疗对ASCVD预防和管理的潜在影响,涵盖了一级和二级预防策略。数字健康工具,如风险评估应用程序、远程监测、生活方式改变支持和远程康复,在提高患者参与度、依从性和治疗效果方面已显示出前景。然而,尽管数字健康干预措施显示出显著益处,但挑战依然存在,包括互操作性问题、隐私担忧、老年人数字素养低以及数字干预措施的医疗保险覆盖范围有限。通过对近期进展和案例研究的分析,本综述表明需要以用户为中心的设计、加强监管框架以及扩大保险支持,以促进数字健康在ASCVD护理中的有效整合。此外,个性化医疗模块等新兴技术为定制化和有影响力的护理提供了有前景的方向。克服这些障碍对于充分发挥数字医疗的潜力以减轻ASCVD负担并改善患者治疗效果至关重要。